Skip to content
2000
Volume 31, Issue 8
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Vitiligo is a disease characterized by skin discoloration, and no safe and effective drugs have been developed until now. New drug research and development are imminent. This article reviews the research on small-molecule drugs for vitiligo from 1990 to 2021 at home and abroad. They are classified according to their structures and mechanisms of action, including natural products and derivatives, anti-oxidative stress drugs, immunosuppressants, prostaglandins, etc. The research on their anti-vitiligo activity, structural modification, new dosage forms, clinical trials, and the development trend in new anti-vitiligo drugs are reviewed, which provides important references for the development of new drugs.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867330666230214103054
2024-03-01
2025-06-28
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867330666230214103054
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test